Slideshow

IL-17, IL-23 Psoriasis Pathway Inhibitors

The development pipeline for psoriasis in summary.

References:

Content provided by our partner site, Managed Healthcare Executive. 

Related Videos
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Melodie Young, ASN, RN: Updates on Therapies for Pediatric Patients with Psoriasis, PsA
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
MEDcast logo
Related Content
Laure Gossec, MD, PhD, Professor of Rheumatology, Pitié-Salpêtrière Hospital and Sorbonne University - Pierre et Marie Curie Campus, Paris, France.
Published: November 23rd 2024 | Updated: November 23rd 2024

Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA

Victoria Johnson
Overdrive Podcast Update: Guselkumab for Treating Active Psoriatic Arthritis Part 2
March 14th 2022

Overdrive Podcast Update: Guselkumab for Treating Active Psoriatic Arthritis Part 2

Lana Pine
People With Psoriatic Arthritis at Risk For Chronic Kidney Disease
November 14th 2024

People With Psoriatic Arthritis at Risk For Chronic Kidney Disease

Victoria Johnson
Overdrive Podcast: Efficacy of Guselkumab for Treating Psoriatic Arthritis
February 23rd 2022

Overdrive Podcast: Efficacy of Guselkumab for Treating Psoriatic Arthritis

Lana Pine
Prof Mikkel Østergaard, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, University of Copenhagen, Denmark
November 7th 2024

Whole-Body MRIs Reveal PsA Inflammation Improvements With Apremilast

Victoria Johnson
HCPLive Rheumatology Month in Review
November 3rd 2024

Rheumatology Month in Review: October 2024

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.